Reappointment of Managing Director

Management Changes View source PDF Explain this filing

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹2655.00

prior close

₹2680.20

announcement price

After-mkt

timing

Nifty Midcap 150market-0.3%-0.2% vs market

Pharmaceuticals peers, median of 165sector+0.0%-0.5% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Midcap 150 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

-2.0

15m

-1.9

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.3-0.2+0.0-0.5

Next day

-4.1-0.1-4.1+0.0-4.1

-2.8-0.5-2.4+0.2-3.0

-2.4-0.2-2.1+0.5-2.9

-2.1+0.2-2.3+0.6-2.7

-2.0+0.2-2.2+0.9-2.9

+0.2+0.5-0.3+0.6-0.4

15d

+13.3+0.5+12.8+0.5+12.8

+11.3-1.1+12.3+1.0+10.2

+3.0-7.1+10.1+2.0+1.0

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GlaxoSmithKline Pharma has announced the reappointment of its Managing Director. The reappointment of the existing Managing Director indicates continuity in leadership and the company's strategic direction. No change in control or management is implied.

Likely market impact

Routine governance action signalling leadership continuity; no immediate material impact on shareholders or operations.